Frank D. Lee insider trades

Open-market stock purchases and sales by Frank D. Lee, Director at Bausch Health Companies Inc, from SEC Form 4 filings since Jun 18, 2020.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +88%.

Recent trades

DateStockTradeValue
May 22, 2026BHC Bausch Health Companies IncBought (not open market)—
May 19, 2026BHC Bausch Health Companies IncSold$133K
Feb 11, 2026PCRX Pacira BioSciences, IncBought (not open market)—
Jan 30, 2026PCRX Pacira BioSciences, IncSold (not open market)$852K
Jan 2, 2026PCRX Pacira BioSciences, IncSold (not open market)$227K

Companies traded

  • BHC Bausch Health Companies Inc: 2 sales, last May 22, 2026
  • PCRX Pacira BioSciences, Inc: 1 buy, last Feb 11, 2026
  • BOLT Bolt Biotherapeutics, Inc: other filings, last Jun 12, 2024
  • FMTX Forma Therapeutics Holdings, Inc: 1 sale, last Oct 14, 2022

Get free alerts when Frank D. Lee files a new trade →